<p>(A) Cells were transfected with 3 MOI lentiviral based shRNA targeting TLR2, TLR4 and RAGE mRNA for 48h. Cells were then treated with 100 ng/mL of HMGB1 for 18 h. Cell migration was detected by in vitro scratch assay. (B) Quantification of cell migration was performed by counting the cell numbers in the rectangle in each sample for 4 fields. Data are expressed as mean ± S.E.M. (n ≥ 3) #p<0.01 as compared with NC group. *p<0.05 as compared with mock group (lentiviral vector negative control). a*p<0.05 as compared with NC treated with HMGB1 100 ng/mL. b*p<0.05 as compared with mock group treated with HMGB1 100 ng/mL.</p
<p>(A) Nuclear NF-κB p65 protein levels in bEnd.3 cells treated with HMGB1 plus different inhibitors...
<p><b>A–C.</b> C6 glioma cells expressing RAGE, RAGEΔICD, or empty vector (mock) were assessed for c...
<p>(A) The mRNA levels of <i>mdr1a</i> in bEnd.3 cells treated with HMGB1 plus different inhibitors....
<p>Cells pretreated with 2 μM of different inhibitors (A) or transfected with lentiviral based shRNA...
<p>Cells were treated with 1, 10, 100 ng/mL HMGB1 for 18h. TLR2, TLR4, and RAGE were detected by imm...
<p>(A&B) The mRNA levels of <i>mdr1a</i> (A) and TLR4 (B) in bEnd.3 cells treated with different con...
<p><b>A–B:</b> RAW 264.7 cells were treated with the indicated amount of HMGB1 and IFN-γ for 18 hour...
<p>Cells were treated with 1, 10, and 100 ng/mL of HMGB1 for 24 h. (A) Cytotoxicity was detected by ...
<p>MRC5 fibroblasts were subjected to migration assays in the presence of (A) human recombinant HMGB...
<p>(A) Transfection with an shRNA knockdown vector for <i>HMGA1</i> in highly aggressive, poorly dif...
<p>Seven genes from the screening hits were confirmed to affect U87 cell migration. (A) Column 1, a ...
<p><b>A–B.</b> C6 glioma cells expressing RAGE, RAGEΔICD, or empty vector (mock) were assessed for S...
HMGB1 (high mobility group box 1 protein) is a nuclear protein that can also act as an extracellular...
<p>(A) HMGB1 was either added to the upper transwell chamber containing the cells (haptotactic stimu...
HMGB1 (high mobility group box 1 protein) is a nuclear protein that can also act as an extracellular...
<p>(A) Nuclear NF-κB p65 protein levels in bEnd.3 cells treated with HMGB1 plus different inhibitors...
<p><b>A–C.</b> C6 glioma cells expressing RAGE, RAGEΔICD, or empty vector (mock) were assessed for c...
<p>(A) The mRNA levels of <i>mdr1a</i> in bEnd.3 cells treated with HMGB1 plus different inhibitors....
<p>Cells pretreated with 2 μM of different inhibitors (A) or transfected with lentiviral based shRNA...
<p>Cells were treated with 1, 10, 100 ng/mL HMGB1 for 18h. TLR2, TLR4, and RAGE were detected by imm...
<p>(A&B) The mRNA levels of <i>mdr1a</i> (A) and TLR4 (B) in bEnd.3 cells treated with different con...
<p><b>A–B:</b> RAW 264.7 cells were treated with the indicated amount of HMGB1 and IFN-γ for 18 hour...
<p>Cells were treated with 1, 10, and 100 ng/mL of HMGB1 for 24 h. (A) Cytotoxicity was detected by ...
<p>MRC5 fibroblasts were subjected to migration assays in the presence of (A) human recombinant HMGB...
<p>(A) Transfection with an shRNA knockdown vector for <i>HMGA1</i> in highly aggressive, poorly dif...
<p>Seven genes from the screening hits were confirmed to affect U87 cell migration. (A) Column 1, a ...
<p><b>A–B.</b> C6 glioma cells expressing RAGE, RAGEΔICD, or empty vector (mock) were assessed for S...
HMGB1 (high mobility group box 1 protein) is a nuclear protein that can also act as an extracellular...
<p>(A) HMGB1 was either added to the upper transwell chamber containing the cells (haptotactic stimu...
HMGB1 (high mobility group box 1 protein) is a nuclear protein that can also act as an extracellular...
<p>(A) Nuclear NF-κB p65 protein levels in bEnd.3 cells treated with HMGB1 plus different inhibitors...
<p><b>A–C.</b> C6 glioma cells expressing RAGE, RAGEΔICD, or empty vector (mock) were assessed for c...
<p>(A) The mRNA levels of <i>mdr1a</i> in bEnd.3 cells treated with HMGB1 plus different inhibitors....